Definition and validation of recompensation in patients with primary biliary cholangitis-related decompensated cirrhosis treated with ursodeoxycholic acid: Based on the BAVENO VII criteria. [PDF]
Ding D +10 more
europepmc +1 more source
Ursodeoxycholic acid relieves clinical severity of COVID-19 in patients with chronic liver diseases. [PDF]
Hu T +5 more
europepmc +1 more source
Mitochondria-targeted nanovesicles for ursodeoxycholic acid delivery to combat neurodegeneration by ameliorating mitochondrial dysfunction. [PDF]
Zhang S +12 more
europepmc +1 more source
The Role of Ursodeoxycholic Acid Administration During the COVID-19 Pandemic: A Questionnaire Survey. [PDF]
Zhou C +6 more
europepmc +1 more source
The effect of ursodeoxycholic acid in dissolving gallstones formed after laparoscopic sleeve gastrectomy: retrospective cohort study. [PDF]
Buyuker F +6 more
europepmc +1 more source
Ursodeoxycholic Acid for the Management of Drug-induced Liver Injury: Role of Hepatoprotective and Anti-cholestatic Mechanisms. [PDF]
Bessone F +4 more
europepmc +1 more source
The effects of ursodeoxycholic acid on cardiometabolic risk factors: a systematic review and meta-analysis of randomized controlled trials. [PDF]
Rashidbeygi E +5 more
europepmc +1 more source

